Histone Signatures Predict Therapeutic Efficacy in Breast Cancer
<italic>Objective:</italic> Regulatory abnormalities caused by chromatin modifications are being increasingly recognized as contributors to cancer. While many molecularly targeted drugs have the potential to revert these modifications, their precise mechanism of action in cellular reprog...
Saved in:
| Main Authors: | Shamim A. Mollah, Shankar Subramaniam |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
IEEE
2020-01-01
|
| Series: | IEEE Open Journal of Engineering in Medicine and Biology |
| Subjects: | |
| Online Access: | https://ieeexplore.ieee.org/document/8961959/ |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Molecular and clinical aspects of histone-related disorders
by: Mode Al Ojaimi, et al.
Published: (2025-04-01) -
Histone variant H3.5 in testicular cell differentiation and its interactions with histone chaperones
by: Patrick Philipp Weil, et al.
Published: (2024-12-01) -
The euchromatic histone mark H3K36me3 preserves heterochromatin through sequestration of an acetyltransferase complex in fission yeast
by: Paula R. Georgescu, et al.
Published: (2020-01-01) -
An overview of potential of natural compounds to regulate epigenetic modifications in colorectal cancer: a recent update
by: Susmita Roy, et al.
Published: (2025-12-01) -
MYC Binding Near Transcriptional End Sites Regulates Basal Gene Expression, Read‐Through Transcription, and Intragenic Contacts
by: Huabo Wang, et al.
Published: (2025-08-01)